// App-Quantinova.ai

4697 : Post-Marketing Safety Experience with Edoxaban in Japan for Thromboprophylaxis Following Major Orthopedic Surgery

Researchers

Presenter

  • Hitoshi Hotoda

Principal Investigators

  • Yasuhiro Nishikawa

  • Akinori Nishiwaki

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Daiichi Sankyo Compa

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Arrhythmia

  • Intracerebral hemorrhage

  • Hematoma

  • Anemia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved